MedPath

DEVINTEC SAGL

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (100.0%)

Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease

Not Applicable
Recruiting
Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
Device: Afluxin®
Drug: Placebo
First Posted Date
2025-05-22
Last Posted Date
2025-08-26
Lead Sponsor
Devintec Sagl
Target Recruit Count
208
Registration Number
NCT06984484
Locations
🇮🇹

IRCCS Policlinico San Martino, Genova, Italy

🇮🇹

IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan, Italy

🇮🇹

AOU Federico II di Napoli, Napoli, Italy

and more 3 locations

Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Not Applicable
Recruiting
Conditions
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Interventions
Device: Gelsectan®
Drug: Placebo
First Posted Date
2024-11-08
Last Posted Date
2024-11-13
Lead Sponsor
Devintec Sagl
Target Recruit Count
330
Registration Number
NCT06681012
Locations
🇮🇹

IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola, Bologna, BO, Italy

🇮🇹

IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milano, Italy

🇮🇹

AOU Federico II di Napoli, Napoli, Italy

and more 5 locations

Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation

Not Applicable
Recruiting
Conditions
Recurrent Aphthous Ulcer
First Posted Date
2023-07-25
Last Posted Date
2023-07-25
Lead Sponsor
Devintec Sagl
Target Recruit Count
46
Registration Number
NCT05959824
Locations
🇮🇹

Policlinico "Umberto I" - U.O.C. di Odontoiatria Pediatrica ed Odontostomatologia, Rome, Italy

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

Not Applicable
Conditions
Irritable Bowel Syndrome With Constipation (IBS-C)
First Posted Date
2022-02-15
Last Posted Date
2022-02-15
Lead Sponsor
Devintec Sagl
Target Recruit Count
60
Registration Number
NCT05240521
Locations
🇧🇬

Outpatient clinic for individual practice for primary medical care Dr. Elenski EOOD, Plovdiv, Bulgaria

🇧🇬

Medical Center Prolet EOOD, Ruse, Bulgaria

🇧🇬

Ambulatory Practice for Primary Outpatient Medical Care SANA OOD, Sofia, Bulgaria

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.